Afya Limited (Nasdaq: AFYA; B3: A2FY34), a prominent medical education group and medical practice solutions provider in Brazil, has announced the approval of a new share repurchase program. The Board of Directors has authorized the repurchase of up to 4,000,000 of its outstanding Class A common shares. The repurchase program will be conducted in open market or privately negotiated transactions starting from August 15, 2025, until the earlier of the completion of the repurchase or December 31, 2026. The repurchase is intended for use in Afya's stock option program, future business combinations, and other corporate purposes. The company plans to fund the repurchases using existing funds and future dividends.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Afya Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001292814-25-003052), on August 13, 2025, and is solely responsible for the information contained therein.